This study is part of an ongoing observational study of the acquisition and maintenance of malaria immunity that began in May 2006. Individuals were invited to be screened for the study after being randomly selected from an age-stratified census of the entire village population. Enrollment exclusion criteria were hemoglobin <7 g/dL, fever ≥37.5°C, acute systemic illness, use of anti-malarial or immunosuppressive medications in the past 30 days, or pregnancy. Venous blood samples and blood smears were collected before the malaria season (May 2006), at cross-sectional time points every 2 months during the malaria season (July, October, and December 2006), prior to the second malaria season (May 2007), and 14 days after the first episode of malaria. Stool and urine were examined at enrollment for the presence of helminth infections. Participants were encouraged to report symptoms of malaria at the village health center, staffed 24 hours per day by a study physician. From those with signs or symptoms of malaria, blood smears were prepared and examined for the presence of P. falciparum. Slide positive patients were treated with a standard 3-day course of artesunate plus amodiaquine, following the guidelines of the Mali National Malaria Control Program. Children with severe malaria were referred to Kati District Hospital after an initial parenteral dose of quinine. The research definition of malaria was an axillary temperature ≥37.5°C, P. falciparum asexual parasitemia ≥5000/μl, and a non-focal physical exam by the study physician. Severe malaria, as defined by the WHO [14 (link)], was included in this definition. At the end of the malaria season, participants (or their parents or guardians in the case of children) were asked whether or not they had used a bednet nightly during the rainy season.
Longitudinal Malaria Immunity Study
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization :
Other organizations : National Institutes of Health, University of Bamako, National Institute of Allergy and Infectious Diseases
Protocol cited in 15 other protocols
Variable analysis
- Presence or absence of malaria infection
- Acquisition and maintenance of malaria immunity
- Presence of helminth infections
- Occurrence of malaria episodes
- Hemoglobin level (≥7 g/dL)
- Absence of fever (≥37.5°C)
- Absence of acute systemic illness
- No use of anti-malarial or immunosuppressive medications in the past 30 days
- Absence of pregnancy
- Positive control: None specified
- Negative control: None specified
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!